In a breakthrough that could potentially rewrite the prevention and treatment of cancer, scientists have discovered how ...

UMass Amherst researchers have developed a groundbreaking nanoparticle-based cancer vaccine that prevented melanoma, ...

Study shows nanoparticle vaccine triggers strong immune response, protecting mice from melanoma, pancreatic, and breast ...

A nanoparticle-based vaccine prevented melanoma, pancreatic, and breast cancers in mice, keeping up to 88% tumor-free and ...

The super adjuvant vaccine also protected against the spread of cancer to the lungs. When exposed to melanoma cells systemically, which mimics how cancer metastasizes, none of the ...

A study led by University of Massachusetts Amherst researchers demonstrates that their nanoparticle-based vaccine can ...

This study directly confronts the issue using nanotechnology to create an adjuvant with two elements. The “super-adjuvant” ...

Across the world, more than 1.5 billion people suffer from chronic liver disease. The U.S. Centers for Disease Control and Prevention reports that it kills more than 52,000 people a year in the United ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Prestigious European Society for Medical Oncology Conference “trials-in-progress” sessionPivotal OVATION 3 trial of its DNA-mediated ...

A study led by University of Massachusetts Amherst researchers demonstrates that their nanoparticle-based vaccine can effectively prevent melanoma, pancreatic and triple-negative breast cancer in mice ...